Back

Socioeconomic trends in oral anticoagulation therapy for atrial fibrillation patients with low risk of stroke

24 April 2021 (15:30 - 16:30)
Organised by:
Congress Presentation Part of: Stroke prevention with and without LAAO Oral Anticoagulation EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Elin Danielsen Lunde

Aalborg University Hospital, Aalborg (Denmark)

7 More presentations in this session

Presentation thumbnail
Left atrial appendage closure in the presence of thrombus: incidence, technique and outcomes
Doctor A. Fontenla Cerezuela (Pozuelo de Alarcon, Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Periprocedural safety and efficacy after left atrial appendage closure in a large UK tertiary centre: 10-year experience
Doctor A. Briosa E Gala (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Is transesophageal echocardiogram mandatory for patients undergoing ablation for right atrial flutter with uninterrupted anticoagulants? A prospective single registry.
Doctor A. Suzat (Saint Priest En Jarez, FR)
Abstract Slides Video
Presentation thumbnail
Short dual antiplatelet strategy following left atrial appendage closure with Watchman and Watchman FLX: 1-year outcomes
Doctor A. Briosa E Gala (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Mitral regurgitation attenuates thrombotic risk in nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier?
Doctor S. Van Laer (Edegem, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke prevention with and without LAAO

The Event

Event poster

EHRA 2021

24 April 2021 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Should we initiate oral anticoagulants for patients with atrial fibrillation staying well without oral anticoagulants for years?
28 August 2022
thumbnail
Congress Presentation
Socioeconomic position, mediators, and risk of atrial fibrillation in a general, adult population
5 April 2025
thumbnail
Congress Presentation
Atrial fibrillation and stroke risk of patients with hypertrophic cardiomyopathy in denmark from 2005-2018: a nationwide cohort study.
3 April 2022
thumbnail
Congress Presentation
A new clinical decision support tool based on personalized evidence-based medicine improves outcomes of anticoagulation therapy in patients with atrial fibrillation: an analysis from the AF Registry
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources